Clinical Trial Update: Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients. [Phase 2, Phase 3]

View source ↗

Summary

A clinical extension study is being conducted to evaluate safety and efficacy of Cellavita-HD in Huntington's disease patients across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Cellavita HD

Snippet

Sponsor: Azidus Brasil | Conditions: Huntington Disease | Phase 2, Phase 3 | Status: UNKNOWN